Over 20 companies including consumer goods companies such as Hamdard Laboratories, Dabur and Sri Sri Tattva have started Ayurvedic, Homeopathic and Unani medicine clinical trials for production of COVID-19 immunity booster therapies.
This comes in the backdrop of AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy) inviting scientific proposals on therapies and procedures that could restrain the spread of the coronavirus pandemic using the Indian system of medicines.
Results from these trials are expected to be announced in two months. AYUSH had earlier called for proposal based on Prime Minister’s advice to work for scientific evidence-based solutions and to enlist various suggestions and proposals from AYUSH practitioners and institutions.